<DOC>
	<DOCNO>NCT01946971</DOCNO>
	<brief_summary>This study crossover study evaluate safety efficacy lansoprazole preterm infant gastroesophageal reflux .</brief_summary>
	<brief_title>Lansoprazole Preterm Infants With Gastroesophageal Reflux ( GER )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>preterm infant symptom suspect gastroesophageal reflux unstable general condition due infection acute illness congenital anomaly upper gastrointestinal tract include esophagus drug history H2 , proton pump inhibitor , blocker last 1 week medication warfarin , carbamazepine , phenytoin , rifampin inappropriate clinical condition judge researcher</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>